Leongini Quoted on the Future of Cosmetics Regulation Under MoCRA
Axios
Partner Emily Cowley Leongini was quoted in a recent Axios article on the Food and Drug Administration’s implementation of the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), which established a July 1 deadline for companies to register their products and facilities with FDA.
Emily said, “It’s like ushering in this new era of cosmetics being a more highly regulated, more meaningfully regulated product…I see it as the beginning of what’s to come.”
Read the full article here and see our Cosmetics team’s June 2024 alert discussing the deadline here. If you are interested in more information about MoCRA, would like guidance on complying with these new requirements, or would like assistance submitting cosmetic facility registrations and cosmetic product listings to FDA, please contact ArentFox Schiff’s Food, Drug, Medical Device & Cosmetic practice group.
